Drugmaker Merck Misrepresented Vioxx

April 16, 2008

From CNBC News, A new report in the Journal of the American Medical Association is highly critical of drugmaker Merck and its handling of the painkiller Vioxx.

The JAMA article says Merck Merck & Co IncMRK
40.34 -0.88 -2.13% NYSE

Quote | Chart | News | Profile
[MRK 40.34 -0.88 (-2.13%) ] misrepresented apparent Vioxx-related deaths in studies to see if the drug worked on Alzheimer’s Disease.

A review of the clinical trials, which came to light during the Vioxx litigation, shows a three-fold increase in the risk of death among the patients who got Vioxx, according to the peer-reviewed medical journal.

But in a press release, Merck says that after careful analysis there was no suggestion the deaths were caused by the drug and that the JAMA report’s conclusions are “false, misleading, or lack context”.

Merck voluntarily pulled Vioxx off the market in 2004 because of an increased heart risk. The company has since settled most of the resulting lawsuits for nearly $5 billion.

One of the two authors of the JAMA article was a paid expert witness for Vioxx plaintiffs.

More Blog Posts


Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law


With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consultation

Live Chat (Online Now)